Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Digital performance testing reveals how redesigned return cannulas can enhance VV-ECMO performance.

Created on 15 Jun 2026

Authors

Beata Ondrusova, Argyrios Petras, Johannes Szasz, Jens Meier, Luca Gerardo-Giorda

Published in

Intensive care medicine experimental. Volume 14. Issue 1. Jun 15, 2026. Epub Jun 15, 2026.

Abstract

Veno-venous extracorporeal membrane oxygenation (VV-ECMO) provides life support for patients with severe respiratory failure by oxygenating blood when the lungs are impaired. Standard VV-ECMO uses two cannulas to drain and return blood. However, recirculation, where oxygenated blood is immediately withdrawn back into the circuit by the drainage cannula, reduces effective oxygen delivery. With survival rates around 62%, optimizing VV-ECMO is essential to improve patient outcomes.
In this study, computational modeling was used to investigate recirculation, oxygen delivery, and the risk of thrombosis and hemolysis for six different return cannula designs under three ECMO flow rates (2, 4, and 6 L/min). Two commercially available and four novel cannulas were tested to evaluate whether design modifications could improve oxygen delivery. Among the novel designs, one was open with additional holes, while the others featured closed or perforated caps.
At low ECMO flow (2 L/min), all cannulas showed similar oxygen saturation (78%) and low recirculation (1.6%), indicating minimal impact of cannula design on VV-ECMO performance. At high flow (6 L/min), closed-tip cannulas reduced recirculation by 40-50% and increased oxygen saturation by 6%, without substantially affecting the risk of thrombosis and hemolysis. Moreover, the partial pressure of oxygen increased by up to 151% compared to the cannula commonly used in clinical practice.
Our findings suggest that new return cannula design could enhance VV-ECMO performance, especially in patients relying predominantly on the support due to severely impaired lung function.

PMID:
42295507
Bibliographic data and abstract were imported from PubMed on 15 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement